{"gene":"MED23","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2003,"finding":"CRSP3/MED23 (chromosome 6) acts as a transcriptional coactivator that functions upstream of TXNIP and KISS1 to suppress melanoma metastasis; CRSP3 transfection upregulates KISS1 and TXNIP expression, and loss of CRSP3 expression correlates with decreased KISS1 and increased metastasis in clinical samples.","method":"Subtractive hybridization, microarray, transfection/overexpression, quantitative RT-PCR","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — functional transfection rescue and expression correlation across multiple melanoma lines, single lab, no direct biochemical interaction assay","pmids":["12543799"],"is_preprint":false},{"year":2004,"finding":"In Drosophila, MED23 is specifically required for heat-shock-induced transcriptional activation and interacts with heat-shock-specific activators; MED16 is required for LPS-induced activation, demonstrating that distinct Mediator subunits interact with specific activators for signal-specific transcription.","method":"RNA interference depletion of individual Mediator subunits, endogenous and synthetic promoter activation assays, microarray","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic RNAi knockdown with functional readout, multiple activator contexts tested, single lab","pmids":["15297616"],"is_preprint":false},{"year":2009,"finding":"MED23 subunit of the Mediator Complex links insulin/MAPK signaling to adipogenesis by interacting with transcription factor ELK1 to drive expression of Krox20, an immediate early gene required for the adipogenic cascade; Med23-null cells fail to recruit a functional preinitiation complex at the Krox20 promoter upon insulin stimulation, and the adipogenic defect is rescued by ectopic Krox20, C/EBPβ, or PPARγ.","method":"Med23 knockout MEFs, knockdown/overexpression, dominant-negative ELK1, rescue experiments, preinitiation complex assay","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO, epistasis rescue, multiple orthogonal functional assays, single lab with multiple complementary approaches","pmids":["19460352"],"is_preprint":false},{"year":2012,"finding":"MED23 regulates alternative mRNA processing by physically interacting with the splicing/polyadenylation factor hnRNP L (identified by tandem affinity purification/mass spectrometry and confirmed by in vitro and in vivo interaction assays); MED23 modulates a subset of hnRNP L-targeted alternative splicing and alternative cleavage and polyadenylation events, and ChIP-seq showed MED23 regulates hnRNP L occupancy at co-regulated genes.","method":"Tandem affinity purification, mass spectrometry, co-IP (in vitro and in vivo), minigene reporters, exon array, ChIP-seq","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (TAP-MS, reciprocal Co-IP, ChIP-seq, functional reporters) establishing direct physical and functional interaction","pmids":["22264826"],"is_preprint":false},{"year":2012,"finding":"MED23 controls a binary cell fate decision between smooth muscle cells (SMCs) and adipocytes from mesenchymal stem cells: Med23 deficiency facilitates SMC differentiation and represses adipocyte differentiation. Mechanistically, MED23 favors ELK1-SRF binding at SMC gene promoters for repression, while absence of MED23 favors MAL-SRF binding at the same promoters for activation of cytoskeletal/SMC genes.","method":"Med23 knockout cells, gene profiling, ChIP, overexpression, zebrafish embryo injection","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO, ChIP demonstrating differential SRF partner binding, in vivo zebrafish validation, multiple orthogonal methods","pmids":["22972934"],"is_preprint":false},{"year":2012,"finding":"MED23 is selectively required for the proliferation and tumorigenicity of Ras-active lung cancer cells; MED23 co-regulates with ELK1 (phosphorylated by MAPK downstream of Ras) a set of cell-cycle/proliferation genes supporting Ras addiction; Med23 deficiency in fibroblasts selectively blocked oncogenic Ras- but not c-Myc-induced transformation.","method":"RNAi screen across lung cancer cell lines, Med23 knockdown, transcriptome analysis, transformation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — large panel screen, genetic epistasis (Ras vs Myc), transcriptome, multiple cell line validation, single lab","pmids":["22988093"],"is_preprint":false},{"year":2013,"finding":"MED23 regulates basal transcription elongation by recruiting the elongation factor P-TEFb through a direct physical interaction with its CDK9 subunit; Med23 deficiency reduces P-TEFb and phospho-Ser2 RNAP II occupancy at the coding region of target genes without altering RNAP II, GTFs, or Mediator occupancy at the promoter, and does not affect DSIF or NELF occupancy.","method":"Co-IP in vivo and in vitro (MED23-CDK9), ChIP, ChIP-seq, qRT-PCR in Med23-null ES cells","journal":"Transcription","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct in vitro binding assay, ChIP-seq, multiple gene targets, mechanistic dissection separating initiation from elongation steps","pmids":["23340209"],"is_preprint":false},{"year":2013,"finding":"MED23 is an anti-viral component of the Mediator complex that inhibits HSV-1 replication by directly interacting with transcription factor IRF7 to upregulate type III interferon (IFN-λ) expression; this anti-viral effect is specific to HSV-1 and does not extend to Vaccinia virus or Semliki Forest virus.","method":"Yeast two-hybrid (MED23-IRF7 interaction), RNAi screen, gain-of-function overexpression, IFN-λ mRNA/protein quantification","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus functional RNAi and overexpression, multiple virus specificity controls, single lab","pmids":["23950709"],"is_preprint":false},{"year":2014,"finding":"Liver-specific Med23 knockout improves glucose and lipid metabolism through modulating the transcriptional activity of FOXO1; MED23 participates in gluconeogenesis and cholesterol synthesis by facilitating Mediator and RNAPII recruitment to FOXO1 target gene promoters; this FOXO1-MED23 functional interaction is evolutionarily conserved in Drosophila fat body.","method":"Liver-specific Med23 knockout mouse, acute hepatic Med23 knockdown (db/db mice), ChIP, Drosophila genetic epistasis","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO, therapeutic knockdown model, ChIP, cross-species genetic validation in Drosophila","pmids":["25223702"],"is_preprint":false},{"year":2014,"finding":"T cell-specific deletion of Med23 leads to hyperactivation of T cells by reducing transcription of multiple negative regulators of T-cell activation; MED23 is required for full MEF2 transcription factor activity, which in turn drives expression of KLF2 (a T-cell master regulatory transcription factor), and loss of KLF2 in MED23-null T cells accounts for failure to populate peripheral lymphoid organs.","method":"Conditional Med23 knockout (Lck-Cre), gene expression profiling, functional assays in MED23-null MEFs for MEF2 activity","journal":"Nature communications / PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO, epistasis through KLF2 and MEF2, single lab, mechanistic link to MEF2 tested in MEFs","pmids":["25301163","25054639"],"is_preprint":false},{"year":2015,"finding":"MED23 is required for H2B monoubiquitination at lysine 120 (H2Bub): MED23 physically associates with the RNF20/40 E3 ubiquitin ligase complex (identified by TAP-MS), and the Mediator complex directly and substantially increases H2Bub on recombinant chromatin in a cell-free system through cooperation with RNF20/40 and the PAF complex. MED23 depletion specifically reduces H2Bub on a subset of MED23-controlled genes genome-wide.","method":"Tandem affinity purification/mass spectrometry, cell-free reconstitution assay with recombinant chromatin, ChIP-seq, genome-wide histone modification profiling","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution on recombinant chromatin, TAP-MS interaction identification, ChIP-seq genome-wide validation, multiple orthogonal methods in single rigorous study","pmids":["26330467"],"is_preprint":false},{"year":2015,"finding":"Med23 depletion enhances neural differentiation of murine ESCs by attenuating BMP signaling; mechanistically, MED23 modulates Bmp4 expression by controlling ETS1 transcription factor activity at the Bmp4 promoter-enhancer; med23 knockdown in zebrafish embryos also enhances neural development, reversed by co-injection of bmp4 mRNA.","method":"Med23 knockdown in ESCs, gene profiling, ChIP, minigene reporter, zebrafish morpholino knockdown with rescue","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods, in vivo zebrafish rescue, single lab","pmids":["25564654"],"is_preprint":false},{"year":2016,"finding":"MED23 physically binds RUNX2 and modulates its transcriptional activity during osteoblast differentiation; Med23 deletion in mesenchymal stem cells or osteoblast precursors reduces Runx2-target gene expression without changing Runx2 levels; Med23 deficiency exacerbates skeletal defects in Runx2+/- mice, establishing genetic interaction.","method":"Conditional Med23 knockout mice, in vitro differentiation assay, co-IP (MED23-RUNX2 binding), gene expression analysis, epistasis (Med23/Runx2 compound mutant)","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — physical interaction by Co-IP, conditional KO, genetic epistasis with Runx2 compound mutant, multiple orthogonal approaches","pmids":["27033977"],"is_preprint":false},{"year":2017,"finding":"MED23 controls pigmentation and DNA repair through the transcription factor MITF: Med23 deficiency impairs pigmentation in melanocyte-lineage cells and zebrafish, and enhances nucleotide excision repair (NER) and reduces UV-induced DNA damage by increasing expression and chromatin recruitment of NER factors; MED23 modulates Mitf expression by controlling its distal enhancer activity.","method":"Med23 conditional knockout in melanocytes, zebrafish knockdown, NER assay, gene expression profiling, ChIP (Mitf enhancer activity)","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO, in vivo zebrafish, ChIP at Mitf enhancer, functional NER assay, single lab","pmids":["28834744"],"is_preprint":false},{"year":2017,"finding":"In C. elegans, SUR-2/MED23 and LIN-1/ELK1 (but not the Cdk8 kinase module) act together to promote endocytic downregulation of LIN-12/Notch-GFP in 1° VPCs and to resist LIN-12/Notch signaling when EGFR is active, integrating EGFR and Notch signaling in vulval precursor cell fate patterning.","method":"C. elegans genetics (sur-2, lin-1, Cdk8 module loss-of-function), cell fate reporter assays, LIN-12-GFP endocytosis assay","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in C. elegans, multiple reporter assays, distinguishes SUR-2/MED23 function from CKM, single lab","pmids":["28954762"],"is_preprint":false},{"year":2018,"finding":"Med23 acts as a gatekeeper of the myeloid potential of hematopoietic stem cells (HSCs): Med23 ablation leads to myeloid-biased differentiation and loss of self-renewal; mechanistically, Med23 maintains stemness gene expression and suppresses myeloid lineage gene expression in HSCs.","method":"Hematopoietic-specific Med23 knockout mice, FACS, gene expression profiling","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with clear lineage phenotypes, gene profiling, single lab","pmids":["30218073"],"is_preprint":false},{"year":2019,"finding":"MED23 suppresses liver fibrosis-related chemokine production (CCL5, CXCL10) by interacting with the orphan nuclear receptor RORα and facilitating G9a (EHMT2)-mediated H3K9 dimethylation at CCL5 and CXCL10 promoters; hepatic Med23 deletion aggravates CCl4-induced fibrosis with enhanced chemokine production and inflammatory infiltration.","method":"Liver-specific Med23 knockout mice, CCl4 fibrosis model, ChIP (H3K9me2), qRT-PCR, mechanistic reporter assays","journal":"PLoS biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO in disease model, ChIP demonstrating histone modification mechanism, single lab","pmids":["31805036"],"is_preprint":false},{"year":2020,"finding":"Med23 binds to the promoter region of Sox9 and represses Sox9 expression in vitro; conditional loss of Med23 in mouse neural crest cells results in upregulated Sox9 and enhanced Sox9-β-catenin binding, leading to reduced Wnt signaling target gene expression, decreased proliferation, and craniofacial defects (micrognathia, cleft palate).","method":"Neural crest-specific Med23 conditional knockout (Wnt1-Cre), ChIP (MED23 at Sox9 promoter), in vitro reporter repression assay, co-IP (Sox9-β-catenin)","journal":"Journal of dental research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO, direct ChIP at Sox9 promoter, in vitro repression assay, single lab","pmids":["33155500"],"is_preprint":false},{"year":2020,"finding":"Med23 deficiency in cranial placode-containing neural tissues is associated with elevated WNT/β-catenin signaling; partial rescue of cranial ganglia defects through combined Lrp6 and Wise loss-of-function places Med23 as a negative regulator of WNT signaling in placode neuronal differentiation.","method":"ENU forward genetic screen (snouty mutant), genetic mapping to Med23, phenotypic analysis, epistasis rescue with Lrp6/Wise loss-of-function","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis rescue in mouse, forward genetic screen identification, single lab","pmids":["33192541"],"is_preprint":false},{"year":2022,"finding":"Med23 maintains vascular integrity by negatively regulating angiopoietin2 (Ang2) expression; endothelial-specific Med23 deletion causes intracranial hemorrhage, impaired angiogenesis, and dilated vessels; knockdown in HUVECs recapitulates these defects cell-autonomously, and inhibition of Ang2 partially rescues angiogenic sprouting and lumen dilation defects.","method":"Endothelial-specific Med23 KO (embryonic lethal), HUVEC knockdown, RNA-seq, Ang2 inhibition rescue in tube formation assay","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO, cell-autonomous HUVEC rescue, Ang2 inhibition functional rescue, single lab","pmids":["35440711"],"is_preprint":false},{"year":2022,"finding":"The ELF3-MED23 protein-protein interaction is mediated by specific hydrogen bonds between residues D400 and H449 of MED23 and W138 and I140 of ELF3; this interaction drives HER2 gene transcription; small molecule YK1 disrupting these H-bonds attenuates HER2-mediated oncogenic signaling in vitro and in vivo.","method":"Fluorescence polarization binding assay, GST pulldown, LC-MS/MS quantitative assay, biosensor assay, in silico structural analysis, SEAP reporter, xenograft mouse model","journal":"Journal of advanced research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal biochemical interaction methods, residue-level mutagenesis/structure mapping, functional cell-based and in vivo validation","pmids":["35963541"],"is_preprint":false},{"year":2024,"finding":"Med23 controls oligodendrocyte differentiation and myelination by modulating Sp1-directed gene programs related to oligodendrocyte differentiation and cholesterol metabolism; mechanistically, Med23 modulates P300 binding to Sp1-targeted genes to orchestrate H3K27 acetylation and enhancer activation for oligodendrocyte lineage progression.","method":"Med23Q649R knock-in mouse, oligodendrocyte-lineage specific Med23 KO, in vitro differentiation assay, gene profiling, reporter assays, ChIP (P300, H3K27ac)","journal":"Cell discovery","confidence":"High","confidence_rationale":"Tier 2 / Strong — patient-variant knock-in model, lineage-specific KO, ChIP demonstrating P300/H3K27ac mechanism, multiple orthogonal approaches","pmids":["39402028"],"is_preprint":false},{"year":2024,"finding":"MED23 interacts with BCLAF1 (identified by Co-IP/mass spectrometry, confirmed by PLA assay); the MED23/BCLAF1 complex regulates expression of NUPR1 (validated by RNA-seq and ChIP); depletion of MED23 triggers premature senescence in NSCLC cells via disruption of autophagic flux downstream of NUPR1.","method":"Co-IP, mass spectrometry, proximity ligation assay (PLA), RNA-seq, ChIP","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction identified by Co-IP/MS and confirmed by PLA, downstream target validated by ChIP, single lab","pmids":["39366174"],"is_preprint":false},{"year":2024,"finding":"Med23 controls muscle stem cell (MuSC) proliferation versus differentiation during muscle regeneration by oppositely regulating TCF/ELK1-SRF-targeted proliferation genes and MRTF-SRF-targeted myogenic differentiation genes; Med23 deficiency decreases ELK1/SRF binding at proliferation gene promoters and promotes MRTF-A/SRF binding at myogenic gene promoters.","method":"MuSC-specific Med23 KO mice, muscle injury model, myofiber culture, integrative genomics, ChIP (ELK1/SRF and MRTF-A/SRF)","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO in vivo and ex vivo, ChIP demonstrating differential SRF partner switching, integrative genomics, multiple orthogonal approaches","pmids":["38691453"],"is_preprint":false},{"year":2025,"finding":"Med23 interacts with the transcription factor FOXO3 to negatively regulate RIG-I expression; Med23 deficiency markedly enhances IFN-I, proinflammatory cytokines, and ISG production in response to RNA virus VSV or poly(I:C); myeloid-specific Med23 KO mice show increased host resistance to VSV infection.","method":"Myeloid-specific Med23 KO mice, multiple cell lines and primary macrophages, co-IP (MED23-FOXO3), qRT-PCR, ELISA, viral challenge","journal":"PLoS biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO in vivo, direct interaction (Co-IP), multiple cell types, single lab","pmids":["40705824"],"is_preprint":false},{"year":2025,"finding":"MED23 collaborates with transcription factor RFX5 to regulate a novel enhancer for IGF2 expression; MED23 deficiency reduces NQO1 protein stability, leading to increased ROS and reduced hepatocyte viability; liver-specific Med23 ablation inhibits HCC development in DEN-induced mouse models.","method":"Constitutive and inducible liver-specific Med23 KO mice, DEN-HCC model, ChIP (RFX5/MED23 at IGF2 enhancer), NQO1 stability assay, ROS measurement, IGF2 overexpression rescue","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO in disease model, ChIP at enhancer, rescue by IGF2 overexpression, single lab","pmids":["41436431"],"is_preprint":false}],"current_model":"MED23 is a tail-module subunit of the Mediator complex that transduces signals from diverse transcription factors (ELK1, RUNX2, FOXO1, IRF7, FOXO3, RFX5, ELF3, Sp1, MITF, RORα, ETS1, MAL/SRF) to RNA polymerase II by physically interacting with these factors and with the elongation factor P-TEFb (via CDK9), by recruiting the RNF20/40 E3 ligase complex to couple H2B monoubiquitination to actively transcribed genes, by modulating P300-mediated H3K27 acetylation at Sp1-targeted enhancers, and by facilitating G9a-mediated H3K9 dimethylation at repressed promoters; through these mechanisms MED23 orchestrates cell fate decisions in adipogenesis, smooth muscle, osteoblast, oligodendrocyte, muscle stem cell, and T-cell lineages, regulates alternative mRNA splicing and polyadenylation via hnRNP L, controls innate immune signaling through IRF7-IFN-λ and FOXO3-RIG-I axes, and modulates energy homeostasis, angiogenesis, and tumor suppression in multiple tissues."},"narrative":{"mechanistic_narrative":"MED23 is a tail-module subunit of the Mediator complex that functions as a signal-specific transcriptional coactivator, transducing inputs from sequence-specific transcription factors to RNA polymerase II to govern lineage-specific gene programs [PMID:15297616, PMID:19460352]. Its defining feature is selectivity: distinct activators engage MED23 to drive context-dependent outputs, exemplified by insulin/MAPK signaling channeled through ELK1 to induce the immediate-early gene Krox20 during adipogenesis, where Med23-null cells fail to assemble a functional preinitiation complex at the Krox20 promoter [PMID:19460352]. MED23 frequently acts as a molecular switch by dictating which partner occupies a shared transcription factor: at SRF-bound promoters MED23 favors ELK1-SRF over MAL/MRTF-SRF binding, thereby toggling cell-fate decisions between smooth muscle/myogenic differentiation and proliferation [PMID:22972934, PMID:38691453]. Beyond preinitiation, MED23 promotes transcription elongation by directly binding the CDK9 subunit of P-TEFb to deposit phospho-Ser2 RNAP II across coding regions [PMID:23340209], and it couples transcription to chromatin by recruiting the RNF20/40 E3 ligase complex—together with the PAF complex—to catalyze H2B K120 monoubiquitination on active genes [PMID:26330467]. MED23 also shapes enhancer chromatin states by modulating P300-directed H3K27 acetylation at Sp1 target genes during oligodendrocyte differentiation [PMID:39402028] and by facilitating G9a-mediated H3K9 dimethylation at repressed chemokine promoters via the nuclear receptor RORα [PMID:31805036]. Through these mechanisms MED23 directs adipocyte, smooth muscle, osteoblast, oligodendrocyte, muscle stem cell, and hematopoietic lineage decisions [PMID:19460352, PMID:27033977, PMID:30218073, PMID:39402028, PMID:38691453], controls hepatic glucose and lipid metabolism through FOXO1 [PMID:25223702], regulates innate antiviral immunity through IRF7-IFNλ and FOXO3-RIG-I axes [PMID:23950709, PMID:40705824], and modulates Ras-driven proliferation and tumorigenesis [PMID:22988093, PMID:35963541, PMID:41436431]. A patient-derived Med23 variant (Q649R) modeled in a knock-in mouse links MED23 to an oligodendrocyte/myelination phenotype [PMID:39402028].","teleology":[{"year":2003,"claim":"Established MED23 (CRSP3) as a transcriptional coactivator with tumor-suppressive output, linking it to metastasis suppressor gene expression before its Mediator mechanism was dissected.","evidence":"Subtractive hybridization, transfection/overexpression and expression correlation across melanoma lines","pmids":["12543799"],"confidence":"Medium","gaps":["No direct physical interaction between MED23 and KISS1/TXNIP regulatory machinery shown","Mechanism of coactivation not resolved at this stage"]},{"year":2004,"claim":"Showed that individual Mediator subunits, including MED23, are required for signal-specific transcriptional activation rather than general transcription, defining the principle of activator-selective Mediator function.","evidence":"RNAi depletion of individual Mediator subunits with promoter activation assays in Drosophila","pmids":["15297616"],"confidence":"Medium","gaps":["Direct activator–MED23 contacts not biochemically mapped","Mammalian generality untested at this point"]},{"year":2009,"claim":"Defined the first molecular pathway for MED23 by showing it links insulin/MAPK signaling to adipogenesis via ELK1-driven Krox20 induction and preinitiation complex assembly.","evidence":"Med23 knockout MEFs, dominant-negative ELK1, and epistasis rescue with Krox20/C/EBPβ/PPARγ","pmids":["19460352"],"confidence":"High","gaps":["Structural basis of MED23–ELK1 contact not defined","Whether the same module operates in other lineages untested here"]},{"year":2012,"claim":"Extended MED23 function beyond promoter activation by demonstrating direct interaction with hnRNP L to regulate alternative splicing and polyadenylation, coupling Mediator to co-transcriptional mRNA processing.","evidence":"TAP-MS, reciprocal Co-IP, ChIP-seq, and minigene reporters","pmids":["22264826"],"confidence":"High","gaps":["Direct binding interface between MED23 and hnRNP L not mapped","Scope of processing events controlled genome-wide only partially defined"]},{"year":2012,"claim":"Revealed MED23 as a binary cell-fate switch that controls SRF cofactor choice (ELK1-SRF vs MAL-SRF), explaining how it directs smooth muscle versus adipocyte differentiation.","evidence":"Med23 knockout cells, ChIP of differential SRF partner binding, zebrafish in vivo validation","pmids":["22972934"],"confidence":"High","gaps":["Mechanism by which MED23 biases SRF partner selection not structurally resolved"]},{"year":2012,"claim":"Connected MED23 to oncogenic Ras dependency by showing it co-regulates ELK1-driven proliferation genes selectively required for Ras-active tumor cells.","evidence":"RNAi screen across lung cancer lines, Ras vs Myc transformation epistasis, transcriptome analysis","pmids":["22988093"],"confidence":"High","gaps":["Therapeutic targetability not addressed at this stage","Direct ELK1–MED23 contact in this context not biochemically isolated"]},{"year":2013,"claim":"Demonstrated a previously unrecognized role for MED23 in transcription elongation through direct CDK9/P-TEFb recruitment, separating its elongation function from preinitiation.","evidence":"In vitro and in vivo MED23–CDK9 Co-IP, ChIP-seq for P-TEFb and Ser2-phospho RNAP II in Med23-null ES cells","pmids":["23340209"],"confidence":"High","gaps":["Domain of MED23 binding CDK9 not mapped","Relationship to activator-specific recruitment not defined"]},{"year":2013,"claim":"Identified MED23 as an antiviral effector that drives IFN-λ via IRF7, linking Mediator to innate immune transcription.","evidence":"Yeast two-hybrid MED23–IRF7, RNAi and overexpression, IFN-λ quantification with virus specificity controls","pmids":["23950709"],"confidence":"Medium","gaps":["IRF7 interaction not confirmed by orthogonal biochemistry beyond Y2H","Why effect is HSV-1-specific unexplained"]},{"year":2014,"claim":"Showed MED23 controls hepatic energy homeostasis by facilitating Mediator/RNAPII recruitment to FOXO1 target genes, an evolutionarily conserved metabolic axis.","evidence":"Liver-specific Med23 KO and acute knockdown in db/db mice, ChIP, Drosophila genetic epistasis","pmids":["25223702"],"confidence":"High","gaps":["Direct MED23–FOXO1 binding interface not mapped","Contribution of elongation vs initiation steps to this output undefined"]},{"year":2014,"claim":"Established MED23 as a restraint on T-cell activation operating through MEF2-driven KLF2 expression, defining an immune lineage role.","evidence":"Conditional Lck-Cre Med23 KO, expression profiling, MEF2 activity assays in MED23-null MEFs","pmids":["25301163","25054639"],"confidence":"Medium","gaps":["Direct MED23–MEF2 physical interaction not demonstrated","Mechanism linking MED23 loss to negative-regulator gene repression incomplete"]},{"year":2015,"claim":"Demonstrated that MED23 couples transcription to chromatin by recruiting RNF20/40 to deposit H2B monoubiquitination, providing a reconstituted biochemical mechanism.","evidence":"TAP-MS, cell-free reconstitution on recombinant chromatin with RNF20/40 and PAF, genome-wide H2Bub ChIP-seq","pmids":["26330467"],"confidence":"High","gaps":["Determinants selecting which genes receive MED23-dependent H2Bub unclear","Interplay with elongation machinery not fully integrated"]},{"year":2015,"claim":"Showed MED23 restrains neural differentiation of ESCs by sustaining BMP signaling through ETS1-directed Bmp4 expression.","evidence":"Med23 knockdown ESCs, ChIP, minigene reporter, zebrafish morpholino rescue with bmp4 mRNA","pmids":["25564654"],"confidence":"Medium","gaps":["Direct MED23–ETS1 binding not biochemically isolated"]},{"year":2016,"claim":"Defined MED23 as a physical and genetic partner of RUNX2 controlling osteoblast differentiation without altering RUNX2 levels.","evidence":"Conditional KO, Co-IP of MED23–RUNX2, Med23/Runx2 compound mutant epistasis","pmids":["27033977"],"confidence":"High","gaps":["Interaction interface unmapped","Whether RUNX2 output uses elongation or chromatin arms of MED23 untested"]},{"year":2017,"claim":"Linked MED23 to pigmentation and DNA repair via MITF enhancer control, broadening its developmental and genome-maintenance reach.","evidence":"Melanocyte conditional KO, zebrafish knockdown, NER assays, ChIP at Mitf enhancer","pmids":["28834744"],"confidence":"Medium","gaps":["Whether MED23 acts directly at NER factor genes or solely through MITF unresolved"]},{"year":2017,"claim":"Showed conserved integration of EGFR and Notch signaling by SUR-2/MED23 with LIN-1/ELK1 in cell-fate patterning, independent of the Cdk8 kinase module.","evidence":"C. elegans genetics, cell-fate reporters, LIN-12-GFP endocytosis assay","pmids":["28954762"],"confidence":"Medium","gaps":["Molecular basis for CKM-independence not defined","Mammalian counterpart of this Notch crosstalk untested"]},{"year":2018,"claim":"Identified MED23 as a gatekeeper of HSC myeloid potential and self-renewal through maintenance of stemness gene expression.","evidence":"Hematopoietic-specific Med23 KO, FACS, expression profiling","pmids":["30218073"],"confidence":"Medium","gaps":["Transcription factor partner driving stemness program not identified","Direct target genes not biochemically mapped"]},{"year":2019,"claim":"Revealed a repressive chromatin mechanism for MED23 in which it cooperates with RORα and G9a to deposit H3K9me2 at chemokine promoters, limiting liver fibrosis.","evidence":"Liver-specific KO in CCl4 model, H3K9me2 ChIP, reporter assays","pmids":["31805036"],"confidence":"Medium","gaps":["Direct MED23–RORα and MED23–G9a contacts not biochemically dissected"]},{"year":2020,"claim":"Positioned MED23 as a repressor of Sox9 and negative regulator of WNT signaling in neural crest, explaining craniofacial defects upon its loss.","evidence":"Wnt1-Cre conditional KO, ChIP at Sox9 promoter, repression reporter, Sox9–β-catenin Co-IP","pmids":["33155500","33192541"],"confidence":"Medium","gaps":["Mechanism by which MED23 represses (vs activates) the Sox9 promoter unresolved","Transcription factor mediating MED23 occupancy at Sox9 not defined"]},{"year":2022,"claim":"Established MED23 as a regulator of vascular integrity by negatively controlling angiopoietin2, with cell-autonomous endothelial requirement.","evidence":"Endothelial-specific KO, HUVEC knockdown, RNA-seq, Ang2 inhibition rescue","pmids":["35440711"],"confidence":"Medium","gaps":["Transcription factor partner directing Ang2 repression unidentified"]},{"year":2022,"claim":"Mapped the MED23–ELF3 interaction at residue resolution and showed pharmacological disruption attenuates HER2 oncogenic signaling, providing a druggable interface.","evidence":"Fluorescence polarization, GST pulldown, residue mutagenesis, SEAP reporter, xenograft with small molecule YK1","pmids":["35963541"],"confidence":"High","gaps":["Crystal structure of the complex not solved","Selectivity of YK1 across other MED23 interactions not fully characterized"]},{"year":2024,"claim":"Showed MED23 drives oligodendrocyte differentiation and myelination by modulating P300-dependent H3K27 acetylation at Sp1 target genes, and linked a patient variant to this program via a knock-in model.","evidence":"Med23Q649R knock-in mouse, lineage-specific KO, ChIP for P300 and H3K27ac, reporter assays","pmids":["39402028"],"confidence":"High","gaps":["How the Q649R variant alters specific molecular contacts not resolved","Direct MED23–Sp1 vs MED23–P300 contact contributions not separated"]},{"year":2024,"claim":"Identified a MED23/BCLAF1 complex regulating NUPR1 and autophagic flux, linking MED23 loss to premature senescence in NSCLC.","evidence":"Co-IP/MS, PLA, RNA-seq, ChIP","pmids":["39366174"],"confidence":"Medium","gaps":["Direct vs indirect nature of NUPR1 regulation not fully separated","Interaction interface with BCLAF1 unmapped"]},{"year":2025,"claim":"Defined opposing MED23 control of SRF cofactor usage (TCF/ELK1-SRF vs MRTF-A/SRF) governing muscle stem cell proliferation versus differentiation during regeneration.","evidence":"MuSC-specific KO, injury model, myofiber culture, ChIP of ELK1/SRF and MRTF-A/SRF, integrative genomics","pmids":["38691453"],"confidence":"High","gaps":["Structural basis of partner switching shared with smooth muscle context not resolved"]},{"year":2025,"claim":"Extended MED23 innate immune function to a FOXO3–RIG-I axis restraining antiviral interferon responses in myeloid cells.","evidence":"Myeloid-specific KO, MED23–FOXO3 Co-IP, viral challenge, cytokine/ISG quantification","pmids":["40705824"],"confidence":"Medium","gaps":["MED23–FOXO3 binding interface unmapped","Relationship to earlier IRF7-IFNλ antiviral role not integrated"]},{"year":2025,"claim":"Showed MED23 promotes hepatocellular carcinoma through an RFX5-directed IGF2 enhancer and NQO1-dependent redox control, marking a tumor-promoting role in liver.","evidence":"Liver-specific KO in DEN-HCC model, ChIP at IGF2 enhancer, NQO1 stability and ROS assays, IGF2 rescue","pmids":["41436431"],"confidence":"Medium","gaps":["Mechanism by which MED23 stabilizes NQO1 protein not defined","How a tumor-promoting hepatic role reconciles with tumor-suppressive roles elsewhere unresolved"]},{"year":null,"claim":"It remains unresolved how MED23 selects among its many transcription factor partners in a given cell type and how its initiation, elongation, and chromatin-modifying activities are coordinated at individual loci.","evidence":"No timeline discovery integrates partner selection with the elongation and histone-modification arms at structural resolution","pmids":[],"confidence":"Low","gaps":["No structural model of MED23 within the Mediator tail engaging activators","Rules governing activation vs repression outputs not defined","Reconciliation of context-dependent tumor-suppressor vs tumor-promoter roles lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,4,23]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,6,10,20]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,6,10,12]}],"localization":[{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[6,10,17]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,4,10]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,6,10]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[10,16,21]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[3]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,4,12,21,23]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,5,14,18]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7,24]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,20,25]}],"complexes":["Mediator complex"],"partners":["ELK1","CDK9","RUNX2","HNRNPL","IRF7","FOXO3","ELF3","BCLAF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9ULK4","full_name":"Mediator of RNA polymerase II transcription subunit 23","aliases":["Activator-recruited cofactor 130 kDa component","ARC130","Cofactor required for Sp1 transcriptional activation subunit 3","CRSP complex subunit 3","Mediator complex subunit 23","Protein sur-2 homolog","hSur-2","Transcriptional coactivator CRSP130","Vitamin D3 receptor-interacting protein complex 130 kDa component","DRIP130"],"length_aa":1368,"mass_kda":156.5,"function":"Required for transcriptional activation subsequent to the assembly of the pre-initiation complex (By similarity). Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional pre-initiation complex with RNA polymerase II and the general transcription factors. Required for transcriptional activation by adenovirus E1A protein. Required for ELK1-dependent transcriptional activation in response to activated Ras signaling","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9ULK4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MED23","classification":"Not Classified","n_dependent_lines":269,"n_total_lines":1208,"dependency_fraction":0.222682119205298},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MED10","stoichiometry":10.0},{"gene":"MED11","stoichiometry":10.0},{"gene":"MED14","stoichiometry":10.0},{"gene":"MED17","stoichiometry":10.0},{"gene":"MED19","stoichiometry":10.0},{"gene":"MED27","stoichiometry":10.0},{"gene":"MED31","stoichiometry":10.0},{"gene":"MED4","stoichiometry":10.0},{"gene":"MED8","stoichiometry":10.0},{"gene":"MED20","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/search/MED23","total_profiled":1310},"omim":[{"mim_id":"614249","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 18, WITH OR WITHOUT EPILEPSY; MRT18","url":"https://www.omim.org/entry/614249"},{"mim_id":"605042","title":"MEDIATOR COMPLEX SUBUNIT 23; MED23","url":"https://www.omim.org/entry/605042"},{"mim_id":"300182","title":"MEDIATOR COMPLEX SUBUNIT 14; MED14","url":"https://www.omim.org/entry/300182"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MED23"},"hgnc":{"alias_symbol":["CRSP130","DRIP130","Sur2"],"prev_symbol":["CRSP3","MRT18"]},"alphafold":{"accession":"Q9ULK4","domains":[{"cath_id":"-","chopping":"2-217","consensus_level":"medium","plddt":83.3931,"start":2,"end":217},{"cath_id":"-","chopping":"295-485","consensus_level":"medium","plddt":90.0704,"start":295,"end":485},{"cath_id":"-","chopping":"502-599","consensus_level":"medium","plddt":89.7982,"start":502,"end":599},{"cath_id":"-","chopping":"617-749","consensus_level":"medium","plddt":85.2689,"start":617,"end":749},{"cath_id":"-","chopping":"754-1000","consensus_level":"medium","plddt":88.5098,"start":754,"end":1000}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9ULK4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9ULK4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9ULK4-F1-predicted_aligned_error_v6.png","plddt_mean":86.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MED23","jax_strain_url":"https://www.jax.org/strain/search?query=MED23"},"sequence":{"accession":"Q9ULK4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9ULK4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9ULK4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9ULK4"}},"corpus_meta":[{"pmid":"12543799","id":"PMC_12543799","title":"Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12543799","citation_count":153,"is_preprint":false},{"pmid":"22264826","id":"PMC_22264826","title":"Mediator complex regulates alternative mRNA processing via the MED23 subunit.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22264826","citation_count":138,"is_preprint":false},{"pmid":"19460352","id":"PMC_19460352","title":"Mediator MED23 links insulin signaling to the adipogenesis transcription cascade.","date":"2009","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/19460352","citation_count":99,"is_preprint":false},{"pmid":"23950709","id":"PMC_23950709","title":"A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.","date":"2013","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/23950709","citation_count":90,"is_preprint":false},{"pmid":"25223702","id":"PMC_25223702","title":"Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.","date":"2014","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/25223702","citation_count":63,"is_preprint":false},{"pmid":"27033977","id":"PMC_27033977","title":"Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27033977","citation_count":63,"is_preprint":false},{"pmid":"22972934","id":"PMC_22972934","title":"Mediator MED23 plays opposing roles in directing smooth muscle cell and adipocyte differentiation.","date":"2012","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/22972934","citation_count":61,"is_preprint":false},{"pmid":"15297616","id":"PMC_15297616","title":"MED16 and MED23 of Mediator are coactivators of lipopolysaccharide- and heat-shock-induced transcriptional activators.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15297616","citation_count":59,"is_preprint":false},{"pmid":"22988093","id":"PMC_22988093","title":"Selective requirement for Mediator MED23 in Ras-active lung cancer.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22988093","citation_count":53,"is_preprint":false},{"pmid":"29203634","id":"PMC_29203634","title":"Mediator Complex Subunits MED2, MED5, MED16, and MED23 Genetically Interact in the Regulation of Phenylpropanoid Biosynthesis.","date":"2017","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/29203634","citation_count":50,"is_preprint":false},{"pmid":"23340209","id":"PMC_23340209","title":"Mediator MED23 regulates basal transcription in vivo via an interaction with P-TEFb.","date":"2013","source":"Transcription","url":"https://pubmed.ncbi.nlm.nih.gov/23340209","citation_count":41,"is_preprint":false},{"pmid":"26330467","id":"PMC_26330467","title":"The Mediator subunit MED23 couples H2B mono-ubiquitination to transcriptional control and cell fate determination.","date":"2015","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/26330467","citation_count":36,"is_preprint":false},{"pmid":"25845469","id":"PMC_25845469","title":"MED23-associated intellectual disability in a non-consanguineous family.","date":"2015","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25845469","citation_count":27,"is_preprint":false},{"pmid":"25301163","id":"PMC_25301163","title":"The mediator subunit Med23 contributes to controlling T-cell activation and prevents autoimmunity.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25301163","citation_count":22,"is_preprint":false},{"pmid":"28834744","id":"PMC_28834744","title":"Mediator MED23 Links Pigmentation and DNA Repair through the Transcription Factor MITF.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28834744","citation_count":18,"is_preprint":false},{"pmid":"31805036","id":"PMC_31805036","title":"Mediator MED23 regulates inflammatory responses and liver fibrosis.","date":"2019","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/31805036","citation_count":17,"is_preprint":false},{"pmid":"25564654","id":"PMC_25564654","title":"Mediator Med23 deficiency enhances neural differentiation of murine embryonic stem cells through modulating BMP signaling.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25564654","citation_count":17,"is_preprint":false},{"pmid":"28954762","id":"PMC_28954762","title":"Integration of EGFR and LIN-12/Notch Signaling by LIN-1/Elk1, the Cdk8 Kinase Module, and SUR-2/Med23 in Vulval Precursor Cell Fate Patterning in Caenorhabditis elegans.","date":"2017","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28954762","citation_count":17,"is_preprint":false},{"pmid":"33155500","id":"PMC_33155500","title":"Med23 Regulates Sox9 Expression during Craniofacial Development.","date":"2020","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/33155500","citation_count":15,"is_preprint":false},{"pmid":"30847200","id":"PMC_30847200","title":"Novel mutation in the MED23 gene for intellectual disability: A case report and literature review.","date":"2019","source":"Clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/30847200","citation_count":14,"is_preprint":false},{"pmid":"37999979","id":"PMC_37999979","title":"LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37999979","citation_count":13,"is_preprint":false},{"pmid":"32850819","id":"PMC_32850819","title":"Mediator Med23 Regulates Adult Hippocampal Neurogenesis.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32850819","citation_count":12,"is_preprint":false},{"pmid":"30218073","id":"PMC_30218073","title":"Med23 serves as a gatekeeper of the myeloid potential of hematopoietic stem cells.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30218073","citation_count":10,"is_preprint":false},{"pmid":"23625751","id":"PMC_23625751","title":"Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.","date":"2013","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23625751","citation_count":10,"is_preprint":false},{"pmid":"33192541","id":"PMC_33192541","title":"The Mediator Subunit, Med23 Is Required for Embryonic Survival and Regulation of Canonical WNT Signaling During Cranial Ganglia Development.","date":"2020","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33192541","citation_count":9,"is_preprint":false},{"pmid":"38195889","id":"PMC_38195889","title":"Med23 deficiency reprograms the tumor microenvironment to promote lung tumorigenesis.","date":"2024","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38195889","citation_count":8,"is_preprint":false},{"pmid":"25273169","id":"PMC_25273169","title":"Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25273169","citation_count":8,"is_preprint":false},{"pmid":"35440711","id":"PMC_35440711","title":"Med23 supports angiogenesis and maintains vascular integrity through negative regulation of angiopoietin2 expression.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35440711","citation_count":7,"is_preprint":false},{"pmid":"28588722","id":"PMC_28588722","title":"MED23 in endocrinotherapy for breast cancer.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28588722","citation_count":7,"is_preprint":false},{"pmid":"35963541","id":"PMC_35963541","title":"Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers.","date":"2022","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/35963541","citation_count":7,"is_preprint":false},{"pmid":"25054639","id":"PMC_25054639","title":"T-cells null for the MED23 subunit of mediator express decreased levels of KLF2 and inefficiently populate the peripheral lymphoid organs.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25054639","citation_count":5,"is_preprint":false},{"pmid":"28220250","id":"PMC_28220250","title":"Differing roles for sur-2/MED23 in C. elegans and C. briggsae vulval development.","date":"2017","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/28220250","citation_count":5,"is_preprint":false},{"pmid":"40113094","id":"PMC_40113094","title":"DNA hypermethylation of MED1 and MED23 as early diagnostic biomarkers for unsolved issues in atrial fibrillation.","date":"2025","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/40113094","citation_count":3,"is_preprint":false},{"pmid":"39402028","id":"PMC_39402028","title":"Mediator MED23 controls oligodendrogenesis and myelination by modulating Sp1/P300-directed gene programs.","date":"2024","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/39402028","citation_count":2,"is_preprint":false},{"pmid":"40114018","id":"PMC_40114018","title":"Central Med23 deficiency leads to malformation of dentate gyrus and ADHD-like behaviors in mice.","date":"2025","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40114018","citation_count":2,"is_preprint":false},{"pmid":"26438725","id":"PMC_26438725","title":"MED23: a new Mediator of H2B monoubiquitylation.","date":"2015","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/26438725","citation_count":2,"is_preprint":false},{"pmid":"39366174","id":"PMC_39366174","title":"MED23 depletion induces premature senescence in NSCLC cells by interacting with BCLAF1 and then suppressing NUPR1 expression.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/39366174","citation_count":1,"is_preprint":false},{"pmid":"39641248","id":"PMC_39641248","title":"Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/39641248","citation_count":1,"is_preprint":false},{"pmid":"41436431","id":"PMC_41436431","title":"Targeting MED23 inhibits hepatocellular carcinoma development by suppressing compensatory proliferation and facilitating ROS-mediated cell death.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41436431","citation_count":1,"is_preprint":false},{"pmid":"40705824","id":"PMC_40705824","title":"Mediator complex subunit MED23 dampens antiviral innate immunity by restricting RIG-I expression.","date":"2025","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/40705824","citation_count":1,"is_preprint":false},{"pmid":"39144687","id":"PMC_39144687","title":"MED23 pathogenic variant: genomic-phenotypic analysis.","date":"2024","source":"Journal of medicine and life","url":"https://pubmed.ncbi.nlm.nih.gov/39144687","citation_count":0,"is_preprint":false},{"pmid":"38691453","id":"PMC_38691453","title":"The Mediator Med23 controls a transcriptional switch for muscle stem cell proliferation and differentiation in muscle regeneration.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/38691453","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.13.676037","title":"Vascular Patterning Shapes Intramembranous Ossification via HIF1α-VEGF Axis","date":"2025-09-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.13.676037","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21023,"output_tokens":6782,"usd":0.0824,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15807,"output_tokens":7001,"usd":0.12703,"stage2_stop_reason":"end_turn"},"total_usd":0.20943,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"CRSP3/MED23 (chromosome 6) acts as a transcriptional coactivator that functions upstream of TXNIP and KISS1 to suppress melanoma metastasis; CRSP3 transfection upregulates KISS1 and TXNIP expression, and loss of CRSP3 expression correlates with decreased KISS1 and increased metastasis in clinical samples.\",\n      \"method\": \"Subtractive hybridization, microarray, transfection/overexpression, quantitative RT-PCR\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — functional transfection rescue and expression correlation across multiple melanoma lines, single lab, no direct biochemical interaction assay\",\n      \"pmids\": [\"12543799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In Drosophila, MED23 is specifically required for heat-shock-induced transcriptional activation and interacts with heat-shock-specific activators; MED16 is required for LPS-induced activation, demonstrating that distinct Mediator subunits interact with specific activators for signal-specific transcription.\",\n      \"method\": \"RNA interference depletion of individual Mediator subunits, endogenous and synthetic promoter activation assays, microarray\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic RNAi knockdown with functional readout, multiple activator contexts tested, single lab\",\n      \"pmids\": [\"15297616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MED23 subunit of the Mediator Complex links insulin/MAPK signaling to adipogenesis by interacting with transcription factor ELK1 to drive expression of Krox20, an immediate early gene required for the adipogenic cascade; Med23-null cells fail to recruit a functional preinitiation complex at the Krox20 promoter upon insulin stimulation, and the adipogenic defect is rescued by ectopic Krox20, C/EBPβ, or PPARγ.\",\n      \"method\": \"Med23 knockout MEFs, knockdown/overexpression, dominant-negative ELK1, rescue experiments, preinitiation complex assay\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO, epistasis rescue, multiple orthogonal functional assays, single lab with multiple complementary approaches\",\n      \"pmids\": [\"19460352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MED23 regulates alternative mRNA processing by physically interacting with the splicing/polyadenylation factor hnRNP L (identified by tandem affinity purification/mass spectrometry and confirmed by in vitro and in vivo interaction assays); MED23 modulates a subset of hnRNP L-targeted alternative splicing and alternative cleavage and polyadenylation events, and ChIP-seq showed MED23 regulates hnRNP L occupancy at co-regulated genes.\",\n      \"method\": \"Tandem affinity purification, mass spectrometry, co-IP (in vitro and in vivo), minigene reporters, exon array, ChIP-seq\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (TAP-MS, reciprocal Co-IP, ChIP-seq, functional reporters) establishing direct physical and functional interaction\",\n      \"pmids\": [\"22264826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MED23 controls a binary cell fate decision between smooth muscle cells (SMCs) and adipocytes from mesenchymal stem cells: Med23 deficiency facilitates SMC differentiation and represses adipocyte differentiation. Mechanistically, MED23 favors ELK1-SRF binding at SMC gene promoters for repression, while absence of MED23 favors MAL-SRF binding at the same promoters for activation of cytoskeletal/SMC genes.\",\n      \"method\": \"Med23 knockout cells, gene profiling, ChIP, overexpression, zebrafish embryo injection\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO, ChIP demonstrating differential SRF partner binding, in vivo zebrafish validation, multiple orthogonal methods\",\n      \"pmids\": [\"22972934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MED23 is selectively required for the proliferation and tumorigenicity of Ras-active lung cancer cells; MED23 co-regulates with ELK1 (phosphorylated by MAPK downstream of Ras) a set of cell-cycle/proliferation genes supporting Ras addiction; Med23 deficiency in fibroblasts selectively blocked oncogenic Ras- but not c-Myc-induced transformation.\",\n      \"method\": \"RNAi screen across lung cancer cell lines, Med23 knockdown, transcriptome analysis, transformation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — large panel screen, genetic epistasis (Ras vs Myc), transcriptome, multiple cell line validation, single lab\",\n      \"pmids\": [\"22988093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MED23 regulates basal transcription elongation by recruiting the elongation factor P-TEFb through a direct physical interaction with its CDK9 subunit; Med23 deficiency reduces P-TEFb and phospho-Ser2 RNAP II occupancy at the coding region of target genes without altering RNAP II, GTFs, or Mediator occupancy at the promoter, and does not affect DSIF or NELF occupancy.\",\n      \"method\": \"Co-IP in vivo and in vitro (MED23-CDK9), ChIP, ChIP-seq, qRT-PCR in Med23-null ES cells\",\n      \"journal\": \"Transcription\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct in vitro binding assay, ChIP-seq, multiple gene targets, mechanistic dissection separating initiation from elongation steps\",\n      \"pmids\": [\"23340209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MED23 is an anti-viral component of the Mediator complex that inhibits HSV-1 replication by directly interacting with transcription factor IRF7 to upregulate type III interferon (IFN-λ) expression; this anti-viral effect is specific to HSV-1 and does not extend to Vaccinia virus or Semliki Forest virus.\",\n      \"method\": \"Yeast two-hybrid (MED23-IRF7 interaction), RNAi screen, gain-of-function overexpression, IFN-λ mRNA/protein quantification\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus functional RNAi and overexpression, multiple virus specificity controls, single lab\",\n      \"pmids\": [\"23950709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Liver-specific Med23 knockout improves glucose and lipid metabolism through modulating the transcriptional activity of FOXO1; MED23 participates in gluconeogenesis and cholesterol synthesis by facilitating Mediator and RNAPII recruitment to FOXO1 target gene promoters; this FOXO1-MED23 functional interaction is evolutionarily conserved in Drosophila fat body.\",\n      \"method\": \"Liver-specific Med23 knockout mouse, acute hepatic Med23 knockdown (db/db mice), ChIP, Drosophila genetic epistasis\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO, therapeutic knockdown model, ChIP, cross-species genetic validation in Drosophila\",\n      \"pmids\": [\"25223702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"T cell-specific deletion of Med23 leads to hyperactivation of T cells by reducing transcription of multiple negative regulators of T-cell activation; MED23 is required for full MEF2 transcription factor activity, which in turn drives expression of KLF2 (a T-cell master regulatory transcription factor), and loss of KLF2 in MED23-null T cells accounts for failure to populate peripheral lymphoid organs.\",\n      \"method\": \"Conditional Med23 knockout (Lck-Cre), gene expression profiling, functional assays in MED23-null MEFs for MEF2 activity\",\n      \"journal\": \"Nature communications / PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO, epistasis through KLF2 and MEF2, single lab, mechanistic link to MEF2 tested in MEFs\",\n      \"pmids\": [\"25301163\", \"25054639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MED23 is required for H2B monoubiquitination at lysine 120 (H2Bub): MED23 physically associates with the RNF20/40 E3 ubiquitin ligase complex (identified by TAP-MS), and the Mediator complex directly and substantially increases H2Bub on recombinant chromatin in a cell-free system through cooperation with RNF20/40 and the PAF complex. MED23 depletion specifically reduces H2Bub on a subset of MED23-controlled genes genome-wide.\",\n      \"method\": \"Tandem affinity purification/mass spectrometry, cell-free reconstitution assay with recombinant chromatin, ChIP-seq, genome-wide histone modification profiling\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution on recombinant chromatin, TAP-MS interaction identification, ChIP-seq genome-wide validation, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"26330467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Med23 depletion enhances neural differentiation of murine ESCs by attenuating BMP signaling; mechanistically, MED23 modulates Bmp4 expression by controlling ETS1 transcription factor activity at the Bmp4 promoter-enhancer; med23 knockdown in zebrafish embryos also enhances neural development, reversed by co-injection of bmp4 mRNA.\",\n      \"method\": \"Med23 knockdown in ESCs, gene profiling, ChIP, minigene reporter, zebrafish morpholino knockdown with rescue\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods, in vivo zebrafish rescue, single lab\",\n      \"pmids\": [\"25564654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MED23 physically binds RUNX2 and modulates its transcriptional activity during osteoblast differentiation; Med23 deletion in mesenchymal stem cells or osteoblast precursors reduces Runx2-target gene expression without changing Runx2 levels; Med23 deficiency exacerbates skeletal defects in Runx2+/- mice, establishing genetic interaction.\",\n      \"method\": \"Conditional Med23 knockout mice, in vitro differentiation assay, co-IP (MED23-RUNX2 binding), gene expression analysis, epistasis (Med23/Runx2 compound mutant)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — physical interaction by Co-IP, conditional KO, genetic epistasis with Runx2 compound mutant, multiple orthogonal approaches\",\n      \"pmids\": [\"27033977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MED23 controls pigmentation and DNA repair through the transcription factor MITF: Med23 deficiency impairs pigmentation in melanocyte-lineage cells and zebrafish, and enhances nucleotide excision repair (NER) and reduces UV-induced DNA damage by increasing expression and chromatin recruitment of NER factors; MED23 modulates Mitf expression by controlling its distal enhancer activity.\",\n      \"method\": \"Med23 conditional knockout in melanocytes, zebrafish knockdown, NER assay, gene expression profiling, ChIP (Mitf enhancer activity)\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO, in vivo zebrafish, ChIP at Mitf enhancer, functional NER assay, single lab\",\n      \"pmids\": [\"28834744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In C. elegans, SUR-2/MED23 and LIN-1/ELK1 (but not the Cdk8 kinase module) act together to promote endocytic downregulation of LIN-12/Notch-GFP in 1° VPCs and to resist LIN-12/Notch signaling when EGFR is active, integrating EGFR and Notch signaling in vulval precursor cell fate patterning.\",\n      \"method\": \"C. elegans genetics (sur-2, lin-1, Cdk8 module loss-of-function), cell fate reporter assays, LIN-12-GFP endocytosis assay\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in C. elegans, multiple reporter assays, distinguishes SUR-2/MED23 function from CKM, single lab\",\n      \"pmids\": [\"28954762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Med23 acts as a gatekeeper of the myeloid potential of hematopoietic stem cells (HSCs): Med23 ablation leads to myeloid-biased differentiation and loss of self-renewal; mechanistically, Med23 maintains stemness gene expression and suppresses myeloid lineage gene expression in HSCs.\",\n      \"method\": \"Hematopoietic-specific Med23 knockout mice, FACS, gene expression profiling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with clear lineage phenotypes, gene profiling, single lab\",\n      \"pmids\": [\"30218073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MED23 suppresses liver fibrosis-related chemokine production (CCL5, CXCL10) by interacting with the orphan nuclear receptor RORα and facilitating G9a (EHMT2)-mediated H3K9 dimethylation at CCL5 and CXCL10 promoters; hepatic Med23 deletion aggravates CCl4-induced fibrosis with enhanced chemokine production and inflammatory infiltration.\",\n      \"method\": \"Liver-specific Med23 knockout mice, CCl4 fibrosis model, ChIP (H3K9me2), qRT-PCR, mechanistic reporter assays\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO in disease model, ChIP demonstrating histone modification mechanism, single lab\",\n      \"pmids\": [\"31805036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Med23 binds to the promoter region of Sox9 and represses Sox9 expression in vitro; conditional loss of Med23 in mouse neural crest cells results in upregulated Sox9 and enhanced Sox9-β-catenin binding, leading to reduced Wnt signaling target gene expression, decreased proliferation, and craniofacial defects (micrognathia, cleft palate).\",\n      \"method\": \"Neural crest-specific Med23 conditional knockout (Wnt1-Cre), ChIP (MED23 at Sox9 promoter), in vitro reporter repression assay, co-IP (Sox9-β-catenin)\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO, direct ChIP at Sox9 promoter, in vitro repression assay, single lab\",\n      \"pmids\": [\"33155500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Med23 deficiency in cranial placode-containing neural tissues is associated with elevated WNT/β-catenin signaling; partial rescue of cranial ganglia defects through combined Lrp6 and Wise loss-of-function places Med23 as a negative regulator of WNT signaling in placode neuronal differentiation.\",\n      \"method\": \"ENU forward genetic screen (snouty mutant), genetic mapping to Med23, phenotypic analysis, epistasis rescue with Lrp6/Wise loss-of-function\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis rescue in mouse, forward genetic screen identification, single lab\",\n      \"pmids\": [\"33192541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Med23 maintains vascular integrity by negatively regulating angiopoietin2 (Ang2) expression; endothelial-specific Med23 deletion causes intracranial hemorrhage, impaired angiogenesis, and dilated vessels; knockdown in HUVECs recapitulates these defects cell-autonomously, and inhibition of Ang2 partially rescues angiogenic sprouting and lumen dilation defects.\",\n      \"method\": \"Endothelial-specific Med23 KO (embryonic lethal), HUVEC knockdown, RNA-seq, Ang2 inhibition rescue in tube formation assay\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO, cell-autonomous HUVEC rescue, Ang2 inhibition functional rescue, single lab\",\n      \"pmids\": [\"35440711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The ELF3-MED23 protein-protein interaction is mediated by specific hydrogen bonds between residues D400 and H449 of MED23 and W138 and I140 of ELF3; this interaction drives HER2 gene transcription; small molecule YK1 disrupting these H-bonds attenuates HER2-mediated oncogenic signaling in vitro and in vivo.\",\n      \"method\": \"Fluorescence polarization binding assay, GST pulldown, LC-MS/MS quantitative assay, biosensor assay, in silico structural analysis, SEAP reporter, xenograft mouse model\",\n      \"journal\": \"Journal of advanced research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal biochemical interaction methods, residue-level mutagenesis/structure mapping, functional cell-based and in vivo validation\",\n      \"pmids\": [\"35963541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Med23 controls oligodendrocyte differentiation and myelination by modulating Sp1-directed gene programs related to oligodendrocyte differentiation and cholesterol metabolism; mechanistically, Med23 modulates P300 binding to Sp1-targeted genes to orchestrate H3K27 acetylation and enhancer activation for oligodendrocyte lineage progression.\",\n      \"method\": \"Med23Q649R knock-in mouse, oligodendrocyte-lineage specific Med23 KO, in vitro differentiation assay, gene profiling, reporter assays, ChIP (P300, H3K27ac)\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — patient-variant knock-in model, lineage-specific KO, ChIP demonstrating P300/H3K27ac mechanism, multiple orthogonal approaches\",\n      \"pmids\": [\"39402028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MED23 interacts with BCLAF1 (identified by Co-IP/mass spectrometry, confirmed by PLA assay); the MED23/BCLAF1 complex regulates expression of NUPR1 (validated by RNA-seq and ChIP); depletion of MED23 triggers premature senescence in NSCLC cells via disruption of autophagic flux downstream of NUPR1.\",\n      \"method\": \"Co-IP, mass spectrometry, proximity ligation assay (PLA), RNA-seq, ChIP\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction identified by Co-IP/MS and confirmed by PLA, downstream target validated by ChIP, single lab\",\n      \"pmids\": [\"39366174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Med23 controls muscle stem cell (MuSC) proliferation versus differentiation during muscle regeneration by oppositely regulating TCF/ELK1-SRF-targeted proliferation genes and MRTF-SRF-targeted myogenic differentiation genes; Med23 deficiency decreases ELK1/SRF binding at proliferation gene promoters and promotes MRTF-A/SRF binding at myogenic gene promoters.\",\n      \"method\": \"MuSC-specific Med23 KO mice, muscle injury model, myofiber culture, integrative genomics, ChIP (ELK1/SRF and MRTF-A/SRF)\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO in vivo and ex vivo, ChIP demonstrating differential SRF partner switching, integrative genomics, multiple orthogonal approaches\",\n      \"pmids\": [\"38691453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Med23 interacts with the transcription factor FOXO3 to negatively regulate RIG-I expression; Med23 deficiency markedly enhances IFN-I, proinflammatory cytokines, and ISG production in response to RNA virus VSV or poly(I:C); myeloid-specific Med23 KO mice show increased host resistance to VSV infection.\",\n      \"method\": \"Myeloid-specific Med23 KO mice, multiple cell lines and primary macrophages, co-IP (MED23-FOXO3), qRT-PCR, ELISA, viral challenge\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO in vivo, direct interaction (Co-IP), multiple cell types, single lab\",\n      \"pmids\": [\"40705824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MED23 collaborates with transcription factor RFX5 to regulate a novel enhancer for IGF2 expression; MED23 deficiency reduces NQO1 protein stability, leading to increased ROS and reduced hepatocyte viability; liver-specific Med23 ablation inhibits HCC development in DEN-induced mouse models.\",\n      \"method\": \"Constitutive and inducible liver-specific Med23 KO mice, DEN-HCC model, ChIP (RFX5/MED23 at IGF2 enhancer), NQO1 stability assay, ROS measurement, IGF2 overexpression rescue\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO in disease model, ChIP at enhancer, rescue by IGF2 overexpression, single lab\",\n      \"pmids\": [\"41436431\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MED23 is a tail-module subunit of the Mediator complex that transduces signals from diverse transcription factors (ELK1, RUNX2, FOXO1, IRF7, FOXO3, RFX5, ELF3, Sp1, MITF, RORα, ETS1, MAL/SRF) to RNA polymerase II by physically interacting with these factors and with the elongation factor P-TEFb (via CDK9), by recruiting the RNF20/40 E3 ligase complex to couple H2B monoubiquitination to actively transcribed genes, by modulating P300-mediated H3K27 acetylation at Sp1-targeted enhancers, and by facilitating G9a-mediated H3K9 dimethylation at repressed promoters; through these mechanisms MED23 orchestrates cell fate decisions in adipogenesis, smooth muscle, osteoblast, oligodendrocyte, muscle stem cell, and T-cell lineages, regulates alternative mRNA splicing and polyadenylation via hnRNP L, controls innate immune signaling through IRF7-IFN-λ and FOXO3-RIG-I axes, and modulates energy homeostasis, angiogenesis, and tumor suppression in multiple tissues.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MED23 is a tail-module subunit of the Mediator complex that functions as a signal-specific transcriptional coactivator, transducing inputs from sequence-specific transcription factors to RNA polymerase II to govern lineage-specific gene programs [#1, #2]. Its defining feature is selectivity: distinct activators engage MED23 to drive context-dependent outputs, exemplified by insulin/MAPK signaling channeled through ELK1 to induce the immediate-early gene Krox20 during adipogenesis, where Med23-null cells fail to assemble a functional preinitiation complex at the Krox20 promoter [#2]. MED23 frequently acts as a molecular switch by dictating which partner occupies a shared transcription factor: at SRF-bound promoters MED23 favors ELK1-SRF over MAL/MRTF-SRF binding, thereby toggling cell-fate decisions between smooth muscle/myogenic differentiation and proliferation [#4, #23]. Beyond preinitiation, MED23 promotes transcription elongation by directly binding the CDK9 subunit of P-TEFb to deposit phospho-Ser2 RNAP II across coding regions [#6], and it couples transcription to chromatin by recruiting the RNF20/40 E3 ligase complex—together with the PAF complex—to catalyze H2B K120 monoubiquitination on active genes [#10]. MED23 also shapes enhancer chromatin states by modulating P300-directed H3K27 acetylation at Sp1 target genes during oligodendrocyte differentiation [#21] and by facilitating G9a-mediated H3K9 dimethylation at repressed chemokine promoters via the nuclear receptor RORα [#16]. Through these mechanisms MED23 directs adipocyte, smooth muscle, osteoblast, oligodendrocyte, muscle stem cell, and hematopoietic lineage decisions [#2, #12, #15, #21, #23], controls hepatic glucose and lipid metabolism through FOXO1 [#8], regulates innate antiviral immunity through IRF7-IFNλ and FOXO3-RIG-I axes [#7, #24], and modulates Ras-driven proliferation and tumorigenesis [#5, #20, #25]. A patient-derived Med23 variant (Q649R) modeled in a knock-in mouse links MED23 to an oligodendrocyte/myelination phenotype [#21].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established MED23 (CRSP3) as a transcriptional coactivator with tumor-suppressive output, linking it to metastasis suppressor gene expression before its Mediator mechanism was dissected.\",\n      \"evidence\": \"Subtractive hybridization, transfection/overexpression and expression correlation across melanoma lines\",\n      \"pmids\": [\"12543799\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct physical interaction between MED23 and KISS1/TXNIP regulatory machinery shown\", \"Mechanism of coactivation not resolved at this stage\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed that individual Mediator subunits, including MED23, are required for signal-specific transcriptional activation rather than general transcription, defining the principle of activator-selective Mediator function.\",\n      \"evidence\": \"RNAi depletion of individual Mediator subunits with promoter activation assays in Drosophila\",\n      \"pmids\": [\"15297616\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct activator–MED23 contacts not biochemically mapped\", \"Mammalian generality untested at this point\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the first molecular pathway for MED23 by showing it links insulin/MAPK signaling to adipogenesis via ELK1-driven Krox20 induction and preinitiation complex assembly.\",\n      \"evidence\": \"Med23 knockout MEFs, dominant-negative ELK1, and epistasis rescue with Krox20/C/EBPβ/PPARγ\",\n      \"pmids\": [\"19460352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of MED23–ELK1 contact not defined\", \"Whether the same module operates in other lineages untested here\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended MED23 function beyond promoter activation by demonstrating direct interaction with hnRNP L to regulate alternative splicing and polyadenylation, coupling Mediator to co-transcriptional mRNA processing.\",\n      \"evidence\": \"TAP-MS, reciprocal Co-IP, ChIP-seq, and minigene reporters\",\n      \"pmids\": [\"22264826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between MED23 and hnRNP L not mapped\", \"Scope of processing events controlled genome-wide only partially defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Revealed MED23 as a binary cell-fate switch that controls SRF cofactor choice (ELK1-SRF vs MAL-SRF), explaining how it directs smooth muscle versus adipocyte differentiation.\",\n      \"evidence\": \"Med23 knockout cells, ChIP of differential SRF partner binding, zebrafish in vivo validation\",\n      \"pmids\": [\"22972934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which MED23 biases SRF partner selection not structurally resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected MED23 to oncogenic Ras dependency by showing it co-regulates ELK1-driven proliferation genes selectively required for Ras-active tumor cells.\",\n      \"evidence\": \"RNAi screen across lung cancer lines, Ras vs Myc transformation epistasis, transcriptome analysis\",\n      \"pmids\": [\"22988093\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Therapeutic targetability not addressed at this stage\", \"Direct ELK1–MED23 contact in this context not biochemically isolated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated a previously unrecognized role for MED23 in transcription elongation through direct CDK9/P-TEFb recruitment, separating its elongation function from preinitiation.\",\n      \"evidence\": \"In vitro and in vivo MED23–CDK9 Co-IP, ChIP-seq for P-TEFb and Ser2-phospho RNAP II in Med23-null ES cells\",\n      \"pmids\": [\"23340209\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domain of MED23 binding CDK9 not mapped\", \"Relationship to activator-specific recruitment not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified MED23 as an antiviral effector that drives IFN-λ via IRF7, linking Mediator to innate immune transcription.\",\n      \"evidence\": \"Yeast two-hybrid MED23–IRF7, RNAi and overexpression, IFN-λ quantification with virus specificity controls\",\n      \"pmids\": [\"23950709\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"IRF7 interaction not confirmed by orthogonal biochemistry beyond Y2H\", \"Why effect is HSV-1-specific unexplained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed MED23 controls hepatic energy homeostasis by facilitating Mediator/RNAPII recruitment to FOXO1 target genes, an evolutionarily conserved metabolic axis.\",\n      \"evidence\": \"Liver-specific Med23 KO and acute knockdown in db/db mice, ChIP, Drosophila genetic epistasis\",\n      \"pmids\": [\"25223702\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct MED23–FOXO1 binding interface not mapped\", \"Contribution of elongation vs initiation steps to this output undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established MED23 as a restraint on T-cell activation operating through MEF2-driven KLF2 expression, defining an immune lineage role.\",\n      \"evidence\": \"Conditional Lck-Cre Med23 KO, expression profiling, MEF2 activity assays in MED23-null MEFs\",\n      \"pmids\": [\"25301163\", \"25054639\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MED23–MEF2 physical interaction not demonstrated\", \"Mechanism linking MED23 loss to negative-regulator gene repression incomplete\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that MED23 couples transcription to chromatin by recruiting RNF20/40 to deposit H2B monoubiquitination, providing a reconstituted biochemical mechanism.\",\n      \"evidence\": \"TAP-MS, cell-free reconstitution on recombinant chromatin with RNF20/40 and PAF, genome-wide H2Bub ChIP-seq\",\n      \"pmids\": [\"26330467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants selecting which genes receive MED23-dependent H2Bub unclear\", \"Interplay with elongation machinery not fully integrated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed MED23 restrains neural differentiation of ESCs by sustaining BMP signaling through ETS1-directed Bmp4 expression.\",\n      \"evidence\": \"Med23 knockdown ESCs, ChIP, minigene reporter, zebrafish morpholino rescue with bmp4 mRNA\",\n      \"pmids\": [\"25564654\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MED23–ETS1 binding not biochemically isolated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined MED23 as a physical and genetic partner of RUNX2 controlling osteoblast differentiation without altering RUNX2 levels.\",\n      \"evidence\": \"Conditional KO, Co-IP of MED23–RUNX2, Med23/Runx2 compound mutant epistasis\",\n      \"pmids\": [\"27033977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interaction interface unmapped\", \"Whether RUNX2 output uses elongation or chromatin arms of MED23 untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linked MED23 to pigmentation and DNA repair via MITF enhancer control, broadening its developmental and genome-maintenance reach.\",\n      \"evidence\": \"Melanocyte conditional KO, zebrafish knockdown, NER assays, ChIP at Mitf enhancer\",\n      \"pmids\": [\"28834744\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MED23 acts directly at NER factor genes or solely through MITF unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed conserved integration of EGFR and Notch signaling by SUR-2/MED23 with LIN-1/ELK1 in cell-fate patterning, independent of the Cdk8 kinase module.\",\n      \"evidence\": \"C. elegans genetics, cell-fate reporters, LIN-12-GFP endocytosis assay\",\n      \"pmids\": [\"28954762\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis for CKM-independence not defined\", \"Mammalian counterpart of this Notch crosstalk untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified MED23 as a gatekeeper of HSC myeloid potential and self-renewal through maintenance of stemness gene expression.\",\n      \"evidence\": \"Hematopoietic-specific Med23 KO, FACS, expression profiling\",\n      \"pmids\": [\"30218073\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcription factor partner driving stemness program not identified\", \"Direct target genes not biochemically mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Revealed a repressive chromatin mechanism for MED23 in which it cooperates with RORα and G9a to deposit H3K9me2 at chemokine promoters, limiting liver fibrosis.\",\n      \"evidence\": \"Liver-specific KO in CCl4 model, H3K9me2 ChIP, reporter assays\",\n      \"pmids\": [\"31805036\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MED23–RORα and MED23–G9a contacts not biochemically dissected\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Positioned MED23 as a repressor of Sox9 and negative regulator of WNT signaling in neural crest, explaining craniofacial defects upon its loss.\",\n      \"evidence\": \"Wnt1-Cre conditional KO, ChIP at Sox9 promoter, repression reporter, Sox9–β-catenin Co-IP\",\n      \"pmids\": [\"33155500\", \"33192541\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which MED23 represses (vs activates) the Sox9 promoter unresolved\", \"Transcription factor mediating MED23 occupancy at Sox9 not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established MED23 as a regulator of vascular integrity by negatively controlling angiopoietin2, with cell-autonomous endothelial requirement.\",\n      \"evidence\": \"Endothelial-specific KO, HUVEC knockdown, RNA-seq, Ang2 inhibition rescue\",\n      \"pmids\": [\"35440711\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcription factor partner directing Ang2 repression unidentified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mapped the MED23–ELF3 interaction at residue resolution and showed pharmacological disruption attenuates HER2 oncogenic signaling, providing a druggable interface.\",\n      \"evidence\": \"Fluorescence polarization, GST pulldown, residue mutagenesis, SEAP reporter, xenograft with small molecule YK1\",\n      \"pmids\": [\"35963541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of the complex not solved\", \"Selectivity of YK1 across other MED23 interactions not fully characterized\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed MED23 drives oligodendrocyte differentiation and myelination by modulating P300-dependent H3K27 acetylation at Sp1 target genes, and linked a patient variant to this program via a knock-in model.\",\n      \"evidence\": \"Med23Q649R knock-in mouse, lineage-specific KO, ChIP for P300 and H3K27ac, reporter assays\",\n      \"pmids\": [\"39402028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the Q649R variant alters specific molecular contacts not resolved\", \"Direct MED23–Sp1 vs MED23–P300 contact contributions not separated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified a MED23/BCLAF1 complex regulating NUPR1 and autophagic flux, linking MED23 loss to premature senescence in NSCLC.\",\n      \"evidence\": \"Co-IP/MS, PLA, RNA-seq, ChIP\",\n      \"pmids\": [\"39366174\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect nature of NUPR1 regulation not fully separated\", \"Interaction interface with BCLAF1 unmapped\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined opposing MED23 control of SRF cofactor usage (TCF/ELK1-SRF vs MRTF-A/SRF) governing muscle stem cell proliferation versus differentiation during regeneration.\",\n      \"evidence\": \"MuSC-specific KO, injury model, myofiber culture, ChIP of ELK1/SRF and MRTF-A/SRF, integrative genomics\",\n      \"pmids\": [\"38691453\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of partner switching shared with smooth muscle context not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended MED23 innate immune function to a FOXO3–RIG-I axis restraining antiviral interferon responses in myeloid cells.\",\n      \"evidence\": \"Myeloid-specific KO, MED23–FOXO3 Co-IP, viral challenge, cytokine/ISG quantification\",\n      \"pmids\": [\"40705824\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MED23–FOXO3 binding interface unmapped\", \"Relationship to earlier IRF7-IFNλ antiviral role not integrated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Showed MED23 promotes hepatocellular carcinoma through an RFX5-directed IGF2 enhancer and NQO1-dependent redox control, marking a tumor-promoting role in liver.\",\n      \"evidence\": \"Liver-specific KO in DEN-HCC model, ChIP at IGF2 enhancer, NQO1 stability and ROS assays, IGF2 rescue\",\n      \"pmids\": [\"41436431\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which MED23 stabilizes NQO1 protein not defined\", \"How a tumor-promoting hepatic role reconciles with tumor-suppressive roles elsewhere unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how MED23 selects among its many transcription factor partners in a given cell type and how its initiation, elongation, and chromatin-modifying activities are coordinated at individual loci.\",\n      \"evidence\": \"No timeline discovery integrates partner selection with the elongation and histone-modification arms at structural resolution\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of MED23 within the Mediator tail engaging activators\", \"Rules governing activation vs repression outputs not defined\", \"Reconciliation of context-dependent tumor-suppressor vs tumor-promoter roles lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 4, 23]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 6, 10, 20]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 6, 10, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [6, 10, 17]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 4, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 6, 10]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [10, 16, 21]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 4, 12, 21, 23]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 5, 14, 18]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7, 24]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 20, 25]}\n    ],\n    \"complexes\": [\n      \"Mediator complex\"\n    ],\n    \"partners\": [\n      \"ELK1\",\n      \"CDK9\",\n      \"RUNX2\",\n      \"hnRNPL\",\n      \"IRF7\",\n      \"FOXO3\",\n      \"ELF3\",\n      \"BCLAF1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}